obesity

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Amgen speaks out about bone density concerns with obesity drug
Clinical Trials Arena
Thu, 11/14/24 - 10:06 am
Amgen
obesity
bone density
MariTide
Gubra's weekly amylin obesity asset well-tolerated, tied to weight loss in phase 1 trial
Fierce Biotech
Wed, 11/13/24 - 09:46 pm
Gubra
obesity
GUBamy
clinical trials
Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1
BioSpace
Wed, 11/13/24 - 11:20 am
Metsera
funding
obesity
Hidden data on obesity prospect wipe $12B off Amgen market cap
Fierce Biotech
Wed, 11/13/24 - 11:10 am
Amgen
MariTide
obesity
clinical trials
Radella reports positive outcomes from trial of MD-18 for obesity and diabetes
Clinical Trials Arena
Fri, 11/8/24 - 11:34 am
Radella Pharmaceuticals
clinical trials
obesity
diabetes
MD-18
Viking data provide latest test of oral obesity drug potential
BioPharma Dive
Mon, 11/4/24 - 06:54 pm
Viking Therapeutics
obesity
clinical trials
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
MSN/Reuters
Mon, 11/4/24 - 11:25 am
AstraZeneca
obesity
clinical trials
Eccogene
Endeveco Bio spin-off to launch obesity trial
Clinical Trials Arena
Mon, 11/4/24 - 11:07 am
Endevica Bio
Abisati
obesity
710GO
Viking Therapeutics Surges, Set To Break Out On Latest Obesity Drug Data
Investors Business Daily
Sun, 11/3/24 - 10:10 pm
Viking Therapeutics
obesity
clinical trials
VK2735
Boehringer Ingelheim drops obesity drug from Gubra partnership
Fierce Biotech
Thu, 10/31/24 - 10:45 pm
Boehringer Ingelheim
Gubra
obesity
Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year
BioSpace
Thu, 10/31/24 - 09:42 am
Amgen
obesity
MariTide
Novo takes big step toward ending Ozempic, Wegovy shortages
BioPharma Dive
Wed, 10/30/24 - 08:48 pm
Novo Nordisk
drug shortages
obesity
Ozempic
Wegovy
Lilly shares fall as obesity drug sales miss forecasts
BioPharma Dive
Wed, 10/30/24 - 11:52 am
Eli Lilly
earnings
obesity
Zepbound
Mounjaro
Weight-loss drugs didn't curb health costs within two years
Reuters
Thu, 10/24/24 - 11:11 am
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
obesity
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Reuters
Thu, 10/24/24 - 09:53 am
Eli Lilly
Mounjaro
Novo Nordisk
Denmark
obesity
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
Motley Fool
Thu, 10/17/24 - 09:24 am
Novartis
GLP-1 agonists
obesity
weight loss
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Novo Nordisk
Eli Lilly
obesity
Zebound
Wegovy
CagriSema
Amgen
MariTide
oforglipron
Veru
enobosarm
nimacimab
Skye Bioscience
Medicare coverage of weight loss drugs would cost $35B: CBO
The Hill
Wed, 10/9/24 - 08:56 pm
Medicare
obesity
weight loss
CBO
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
R&D
obesity
weight loss
Novo Nordisk
Eli Lilly
Roche
Boehringer Ingelheim

Pages